scispace - formally typeset
N

Nichola Johnson

Researcher at Institute of Cancer Research

Publications -  87
Citations -  11655

Nichola Johnson is an academic researcher from Institute of Cancer Research. The author has contributed to research in topics: Breast cancer & Genome-wide association study. The author has an hindex of 44, co-authored 79 publications receiving 10336 citations. Previous affiliations of Nichola Johnson include The Breast Cancer Research Foundation.

Papers
More filters
Journal ArticleDOI

Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.

Shahana Ahmed, +144 more
- 29 Mar 2009 - 
TL;DR: Strong evidence is found for additional susceptibility loci on 3p and 17q and potential causative genes include SLC4A7 and NEK10 on3p and COX11 on 17q.
Journal ArticleDOI

Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

Nasim Mavaddat, +242 more
TL;DR: The PRS stratifies breast cancer risk in women both with and without a family history of breast cancer, and the observed level of risk discrimination could inform targeted screening and prevention strategies.
Journal ArticleDOI

Genome-wide association studies identify four ER negative-specific breast cancer risk loci

Montserrat Garcia-Closas, +287 more
- 01 Apr 2013 - 
TL;DR: SNPs at four loci were associated with ER-negative but not ER-positive breast cancer (P > 0.05), providing further evidence for distinct etiological pathways associated with invasive ER- positive and ER- negative breast cancers.
Journal ArticleDOI

Genome-wide association analysis identifies three new breast cancer susceptibility loci

Maya Ghoussaini, +197 more
- 22 Jan 2012 - 
TL;DR: Three new breast cancer risk loci are identified at 12p11, 12q24 and 21q21, which lie in regions that contain strong plausible candidate genes: PTHLH has a crucial role in mammary gland development and the establishment of bone metastasis in breast cancer, and NRIP1 encodes an ER cofactor and has a role in the regulation of breast cancer cell growth.
Journal ArticleDOI

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

Roger L. Milne, +512 more
- 23 Oct 2017 - 
TL;DR: A genome-wide association study (GWAS) of predominantly estrogen receptor (ER)-positive disease and BRCA1 mutation carrier GWAS observed consistent associations with ER-negative disease for 105 susceptibility variants identified by other studies, which explain approximately 16% of the familial risk of this breast cancer subtype.